ARCHIVES

Phase III Trial Would Give Clearer Picture Of C225 Role.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

DeVita takes Over As NCI Acing Director; Search Begins For New Permanent Chief

January 4, 1980

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

Appropriations Committees Lean Toward Adding Some To NCI Budget; ACS To Ask Again For $1.5 Billion

April 20, 1984

President Obama Signs Spending Bill Giving NCI 2.8 Percent Increase

December 18, 2009